High Blood Pressure in Sub-Saharan Africa: Why Prevention, Detection, and Control are Urgent and Important

Journal of Clinical Hypertension

Volumn 17, Issue 9, 2015, Pages 663-667

  Campbell, Norm R C ^a   Bovet, Pascal ^b   Schutte, Aletta Elisabeth ^c   Lemogoum, Daniel ^d   Nkwescheu, Armand Seraphin ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c NORTH WEST UNIVERSITY   (South Africa)

^d UNIVERSITY OF DOUALA   (Cameroon)

^e Ministry of Public Health of Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

WATER;

AFRICA SOUTH OF THE SAHARA; ALCOHOL CONSUMPTION; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEMENTIA; DIABETES MELLITUS; DYSLIPIDEMIA; EVIDENCE BASED PRACTICE; FETUS DEATH; FOOD PROCESSING; FRUIT; FRUIT JUICE; GOVERNMENT; GRAIN; HEALTH CARE POLICY; HEALTH PRACTITIONER; HEALTH SERVICE; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; LIFESTYLE MODIFICATION; LONG TERM CARE; MATERNAL MORTALITY; NON COMMUNICABLE DISEASE; OBESITY; OUTCOME ASSESSMENT; PHYSICAL INACTIVITY; POTASSIUM INTAKE; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SALT INTAKE; SODIUM INTAKE; TOBACCO USE; VEGETABLE; WELLBEING; WORLD HEALTH ORGANIZATION; HEALTH CARE DELIVERY; PROCEDURES; RISK ASSESSMENT; RISK REDUCTION;

AFRICA SOUTH OF THE SAHARA; DELIVERY OF HEALTH CARE; HUMANS; HYPERTENSION; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 84940893976     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12599     Document Type: Article

References (34)

1. Campbell NR, Niebylski M, Lackland D. High blood pressure: why prevention and control are urgent and important. A 2014 Fact Sheet from the World Hypertension League and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:551-553. DOI: 10.1111/jch.12372.
2. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2224-2260.
3. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2197-2223.
4. World Health Organization. A global brief on hypertension: silent killer, global public health crisis. World Health Day 2013. Report, 1-39. Geneva, Switzerland, World Health Organization; 2013.
5. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
6. Udani S, Lazich I, Bakris GL. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 2011;7:11-21.
7. Levi MN, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31:1073-1082.
8. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-1074.
9. Seely EW, Maxwell C. Cardiology patient page. Chronic hypertension in pregnancy. Circulation. 2007;115:e188-e190.
10. Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891-897.
11. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA. 2002;287:1003-1010.
12. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
13. World Health Organization. Noncommunicable diseases country profiles 2014. Report, 1-207. Geneva, Switzerland, World Health Organization; 2014.
14. Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377:568-577.
15. Seedat YK. Control of hypertension in South Africa: time for action. S Afr Med J. 2012;102:25-26.
16. Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart. 2013;99:1390-1397.
17. Bovet P, Gervasoni JP, Ross AG, et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens. 2003;21:509-517.
18. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:1472-1477.
19. Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S. Population, Institute of Medicine of the National Academies. A population-based policy and systems change approach to prevent and control hypertension. Report, v-173. Washington, DC, National Academies Press; 2010.
20. Charlton KE, Steyn K, Levitt NS, et al. Diet and blood pressure in South Africa: intake of foods containing sodium, potassium, calcium, and magnesium in three ethnic groups. Nutrition. 2005;21:39-50.
21. Schutte AE, Schutte R, Huisman HW, et al. Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study. Int J Epidemiol. 2012;41:1114-1123.
22. Luft FC, Miller JZ, Grim CE, et al. Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension. 1991;17(Suppl 1):I102-I108.
23. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27(3 Pt 2):481-490.
24. Powles J, Fahimi S, Micha R, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733.
25. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791-813.
26. World Health Organization. WHO global status report on noncommunicable diseases 2010. Report, iii-161. Geneva, Switzerland, WHO Press, World Health Organization; 2011.
27. Mozaffarian D, Afshin A, Benowitz NL, et al. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation. 2012;126:1514-1563.
28. Wilson JF. Can disease prevention save health reform? Ann Intern Med. 2009;151:145-148.
29. World Health Organization. Diet, nutrition and the prevention of chronic diseases: report of a Joint WHO/FAO Expert Consultation. World Health Organization 1, 1-149. Geneva, Switzerland, World Health Organization; 2003.
30. United Nations General Assembly. Political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases-draft resolution submitted by the President of the General Assembly. Report, 1-13. New York, NY, United Nations; 2011.
31. Moran AE, Odden MC, Thanataveerat A, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015;372:447-455.
32. World Health Organization. WHO global action plan for the prevention and control of noncommunicable diseases 2013-2020. Report, III-103. Geneva, Switzerland, WHO Press, World Health Organization; 2013.
33. World Health Organization. WHO package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. Report, 1-65. Geneva, Switzerland, World Health Organization; 2010.
34. Mayosi BM. The 10 'Best Buys' to combat heart disease, diabetes and stroke in Africa. Heart. 2013;99:973-974.